Author Archives: admin


New technique allows scientists to find rare stem cells within bone marrow

13 hours ago by Anne Trafton MIT and SMART researchers have developed a way to isolate mesenchymal stem cells based on physical traits such as stiffness. Credit: MIT

Deep within the bone marrow resides a type of cells known as mesenchymal stem cells (MSCs). These immature cells can differentiate into cells that produce bone, cartilage, fat, or musclea trait that scientists have tried to exploit for tissue repair.

In a new study that should make it easier to develop such stem-cell-based therapies, a team of researchers from MIT and the Singapore-MIT Alliance in Research and Technology (SMART) has identified three physical characteristics of MSCs that can distinguish them from other immature cells found in the bone marrow. Based on this information, they plan to create devices that could rapidly isolate MSCs, making it easier to generate enough stem cells to treat patients.

Until now, there has been no good way to separate MSCs from bone marrow cells that have already begun to differentiate into other cell types, but share the same molecules on the cell surface. This may be one reason why research results vary among labs, and why stem-cell treatments now in clinical trials are not as effective as they could be, says Krystyn Van Vliet, an MIT associate professor of materials science and engineering and biological engineering and a senior author of the paper, which appears in the Proceedings of the National Academy of Sciences this week.

"Some of the cells that you're putting in and calling stem cells are producing a beneficial therapeutic outcome, but many of the cells that you're putting in are not," Van Vliet says. "Our approach provides a way to purify or highly enrich for the stem cells in that population. You can now find the needles in the haystack and use them for human therapy."

Lead authors of the paper are W.C. Lee, a former graduate student at the National University of Singapore and SMART, and Hui Shi, a former SMART postdoc. Other authors are Jongyoon Han, an MIT professor of electrical engineering and biological engineering, SMART researchers Zhiyong Poon, L.M. Nyan, and Tanwi Kaushik, and National University of Singapore faculty members G.V. Shivashankar, J.K.Y. Chan, and C.T. Lim.

Physical markers

MSCs make up only a small percentage of cells in the bone marrow. Other immature cells found there include osteogenic cells, which have already begun the developmental path toward becoming cartilage- or bone-producing cells. Currently, researchers try to isolate MSCs based on protein markers found on the cell surfaces. However, these markers are not specific to MSCs and can also yield other types of immature cells that are more differentiated.

"Conventional cell-surface markers are frequently used to isolate different types of stem cells from the human bone marrow, but they lack sufficient 'resolution' to distinguish between subpopulations of mesenchymal stromal cells with distinct functions," Lee says.

The researchers set out to find biophysical markers for multipotencythe ability to become many different cell types. They first suspected that cell size might be a factor, because fetal bone marrow stem cells, which tend to have a higher percentage of MSCs, are usually small in diameter.

See the rest here:
New technique allows scientists to find rare stem cells within bone marrow

Stem Cells, Malaria, and the Genetics of Drug Response at Translational Medicine Symposium

PUBLIC RELEASE DATE:

6-Oct-2014

Contact: Karen Kreeger karen.kreeger@uphs.upenn.edu 215-349-5658 University of Pennsylvania School of Medicine @PennMedNews

PHILADELPHIA The University of Pennsylvania's Institute for Translational Medicine and Therapeutics' 9th Annual International Symposium (ITMAT), Progress in Translational Science: Emerging Therapeutic Modalities, will be held on October 13-14. The symposium will feature outstanding speakers from the United States and abroad to address topics at the core of translational science. Speakers will include experts researching advances in stem cell biology, single cell metabolomics, and infectious diseases.

Date: Monday and Tuesday, October 13 - 14, 2013, starting at 8:30 am.

Location: Smilow Center for Translational Research, Rubenstein Auditorium and Lobby, 3400 Civic Center Blvd, Philadelphia, PA 19104

Additional Details

The symposium will feature presentations in six major areas:

Garret A. FitzGerald, MD, Director of ITMAT, will host the event. Speakers and talks include:

Carl H. June, MD, Richard W. Vague Professor in Immunotherapy, Program Director of Translational Research, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Driving CARs for cancer: are we there yet?

More:
Stem Cells, Malaria, and the Genetics of Drug Response at Translational Medicine Symposium

UCI stem cell scientist wins coveted NIH New Innovator Award

PUBLIC RELEASE DATE:

6-Oct-2014

Contact: Tom Vasich tmvasich@uci.edu 949-824-6455 University of California - Irvine @UCIrvine

Irvine, Calif., Oct. 6, 2014 UC Irvine scientist Weian Zhao will receive a prestigious National Institutes of Health Director's New Innovator Award to further his efforts to create stem cell-based detection methods and treatments for cancer.

It's part of the highly selective High Risk-High Reward Research Award Program and supports projects by early-career biomedical researchers with the potential to transform scientific fields and accelerate the translation of research into new ways to improve human health.

Zhao, an assistant professor of pharmaceutical sciences, will get $1.5 million over five years. He's among 50 investigators selected for the 2014 award.

His project is to engineer smart stem cell systems to effectively detect and treat the spread of cancer in the body. Cancer metastases are responsible for more than 90 percent of cancer deaths; however, few current therapies directly target metastatic cancer.

Zhao's goal is to have stem cell messengers selectively migrate to cancer sites to deliver tumor-fighting drugs or probes for contrast-enhanced medical imaging. This could, potentially, enable the identification of cancer micro-metastases at their early stages and increase the effectiveness of chemotherapeutic treatments for metastatic cancer while mitigating the symptoms associated with systemic chemotherapy.

"It's a great honor to receive this prestigious award," he said. "In particular, its high-risk-high-reward spirit gives us the freedom to pursue out-of-the-box approaches to the biggest challenge in cancer."

Zhao is a member of the Sue & Bill Gross Stem Cell Research Center and the Chao Family Comprehensive Cancer Center at UCI, with a joint appointment in the Department of Biomedical Engineering. He has received numerous awards and was named to MIT Technology Review's 2012 TR35 list of the world's top 35 innovators under the age of 35.

Read the original:
UCI stem cell scientist wins coveted NIH New Innovator Award

Stem Cells, Malaria, and the Genetics of Drug Response Highlighted at Penn's 9th Annual Translational Medicine Symposium

Contact Information

Available for logged-in reporters only

Newswise PHILADELPHIA The University of Pennsylvanias Institute for Translational Medicine and Therapeutics 9th Annual International Symposium (ITMAT), Progress in Translational Science: Emerging Therapeutic Modalities, will be held on October 13-14. The symposium will feature outstanding speakers from the United States and abroad to address topics at the core of translational science. Speakers will include experts researching advances in stem cell biology, single cell metabolomics, and infectious diseases.

Date: Monday and Tuesday, October 13 - 14, 2013, starting at 8:30 am.

Location: Smilow Center for Translational Research, Rubenstein Auditorium and Lobby, 3400 Civic Center Blvd, Philadelphia, PA 19104

Additional details:

The symposium will feature presentations in six major areas:

Challenges and Opportunities in Translational Research Stem Cell Therapeutics Movement in Malaria Focus on the Single Cell Variability in Drug Response Translational Immunology

Garret A. FitzGerald, MD, Director of ITMAT, will host the event. Speakers and talks include:

Kenneth S. Zaret, PhD, Joseph Leidy Professor of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania Discovering networks and diagnostics for pancreatic cancer progression

See the rest here:
Stem Cells, Malaria, and the Genetics of Drug Response Highlighted at Penn's 9th Annual Translational Medicine Symposium

BioEden the specialist tooth stem cell bank plan to shake up public perception as Stem Cell Awareness week takes hold.

(PRWEB UK) 7 October 2014

Stem cell treatments take place in countries all around the world every day. Thousands of lives have already been saved, and advancements in this area of medicine means that future healthcare treatments look set to further prolong and improve life.

But specialist stem cell bank BioEden warn that there is a risk of thinking of stem cell therapy in terms of the future alone. 'The need to have a stem cell match is vital', says Group CEO Mr Tony Veverka. 'Without access to a stem cell match, the work of stem cell scientists could be at risk. That is the reason why BioEden was set up, to ensure that anyone could bank and have access to their own stem cells. We also wanted to ensure that the brilliant work being carried out by stem cell scientists and medical professionals could continue unhindered'.

BioEden's services are being promoted by Health Care Professionals including specialist insurance intermediaries, and dentists. This week to highlight Stem Cell Awareness week, members of their specialist teams will be on the road visiting dentists, schools and healthcare insurance companies.

'Let's make everyone aware of the opportunities they have to store their own cells during stem cell awareness week. Perhaps we need to re name it Stem Cell Self-Awareness week'.

For more information visit http://www.bioeden.com

View post:
BioEden the specialist tooth stem cell bank plan to shake up public perception as Stem Cell Awareness week takes hold.

SCI 1 1 Xiaoyanzi-(Female,36-year-old)-C4-C5 Spinal Cord Injury- Before stem cell treatment – Video


SCI 1 1 Xiaoyanzi-(Female,36-year-old)-C4-C5 Spinal Cord Injury- Before stem cell treatment
Xiaoyanzi is a Chinese 36 years old female patient suffering from spinal cord injury. She underwent a car crash in June, 2014, then was diagnosed as C4-C5 vertebral bodies fracture with relevant...

By: Stem Cells

See the rest here:
SCI 1 1 Xiaoyanzi-(Female,36-year-old)-C4-C5 Spinal Cord Injury- Before stem cell treatment - Video

SCI1 2 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-After the 1st round stem cell treatment – Video


SCI1 2 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-After the 1st round stem cell treatment
Xiaoyanzi is a Chinese 36 years old female patient suffering from spinal cord injury. She underwent a car crash in June, 2014, then was diagnosed as C4-C5 vertebral bodies fracture with relevant...

By: Stem Cells

Go here to see the original:
SCI1 2 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-After the 1st round stem cell treatment - Video

1 3 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-Before the 2nd round stem cell treatmentnt – Video


1 3 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-Before the 2nd round stem cell treatmentnt
Xiaoyanzi is a Chinese 36 years old female patient suffering from spinal cord injury. She underwent a car crash in June, 2014, then was diagnosed as C4-C5 vertebral bodies fracture with relevant...

By: Stem Cells

Original post:
1 3 Xiaoyanzi-(Male,1-year-old)-C4-C5 Spinal Cord Injury-Before the 2nd round stem cell treatmentnt - Video